Pharmacy Usual Items - Southeast Asia

Southeast Asia

Highlights

Revenue in the Pharmacy Usual Items market is projected to reach US$23.92bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 3.72%, resulting in a market volume of US$28.71bn by 2029.
In global comparison, most revenue will be generated China (US$48.05bn in 2024).
In relation to total population figures, per person revenues of US$34.53 are generated in 2024.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Pharmacy Usual Items market in Southeast Asia is experiencing significant growth and development.

Customer preferences: Customers in Southeast Asia have shown a growing preference for Pharmacy Usual Items. This can be attributed to several factors including an increasing awareness of health and wellness, a growing aging population, and a rising middle class with higher disposable incomes. Additionally, the convenience and accessibility of Pharmacy Usual Items have made them a popular choice among consumers in the region.

Trends in the market: One of the key trends in the Pharmacy Usual Items market in Southeast Asia is the increasing demand for over-the-counter (OTC) medications and healthcare products. This can be attributed to the rising self-medication trend, where consumers are taking a more proactive approach to managing their health. As a result, there has been a surge in the sales of OTC medications such as pain relievers, cough and cold remedies, and vitamins and supplements. Another trend in the market is the growing popularity of natural and herbal remedies. Consumers in Southeast Asia are increasingly seeking out alternative healthcare options that are perceived to be more natural and holistic. This has led to an increase in the demand for traditional medicines and herbal supplements, which are often sourced from local plants and herbs.

Local special circumstances: Southeast Asia is a diverse region with a wide range of cultural and traditional practices. This diversity is reflected in the Pharmacy Usual Items market, where different countries have their own unique preferences and demands. For example, in countries like Thailand and Indonesia, traditional medicine and herbal remedies are deeply rooted in the local culture and are widely used alongside modern pharmaceutical products. On the other hand, in more developed economies like Singapore and Malaysia, there is a greater reliance on Western medicine and pharmaceutical products.

Underlying macroeconomic factors: The growth of the Pharmacy Usual Items market in Southeast Asia can also be attributed to several underlying macroeconomic factors. Firstly, the region has been experiencing strong economic growth, which has led to an increase in disposable incomes and improved living standards. This has resulted in a higher demand for healthcare products and services, including Pharmacy Usual Items. Additionally, the aging population in Southeast Asia is driving the demand for Pharmacy Usual Items. As the population ages, there is a greater need for medications and healthcare products to manage chronic conditions and age-related ailments. This demographic shift is expected to continue in the coming years, further driving the growth of the Pharmacy Usual Items market. In conclusion, the Pharmacy Usual Items market in Southeast Asia is experiencing significant growth and development. Customer preferences for OTC medications, natural remedies, and traditional medicines are driving the demand for Pharmacy Usual Items. The diverse cultural and traditional practices in the region also influence the market dynamics. Overall, the growth of the Pharmacy Usual Items market can be attributed to the region's strong economic growth, increasing disposable incomes, and aging population.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.